Search

23 Oct 2020: BlueGnome, which was founded in 2002 by Cambridge graduate Dr Nick Haan and Graham Snudden, is one of the fastest-growing biotechnology companies in the UK.

23 Oct 2020: The enterprise awards, made annually by HM The Queen, are given for the highest levels of excellence demonstrated in each category. Read more here.

23 Oct 2020: Cambridge, Edinburgh, Imperial, Oxford, Manchester and UCL have collaborated to produce a briefing paper: Golden Shares & Anti-dilution Provisions.

23 Oct 2020: Read more about Horizon Discovery announcing their collaboration with AstraZeneca.

23 Oct 2020: Apollo, the investment fund focused on driving therapeutic innovation through university collaboration, has appointed Dr Richard Butt as CEO.

23 Oct 2020: A clinical trial with this age group is testing an ‘artificial pancreas’, developed by the group of Dr Roman Hovorka. Read more here.

23 Oct 2020: New voice recognition software that interprets the spoken word is poised to revolutionise voice recognition systems. Read more here.

23 Oct 2020: Cambridge Innovation Capital (CIC), a preferred investor for Cambridge Enterprise, has increased its holding in Cambridge Medical Robotics Ltd.

23 Oct 2020: Steve Langan, Managing Director of Hiscox UK and Ireland, the title sponsor of the league table, commented: “Just as London 2012 will inspire young athletes, so too should the stories behind

23 Oct 2020: Cambridge Enterprise sister organisation Cambridge Innovation Capital plc leads a $14 million Series B funding round in Undo, a pioneer in the development of new software debugging technologies. The funding will be used to grow Undo’s team,

23 Oct 2020: Lynparza was developed by KuDOS Pharmaceuticals Ltd., which was founded in 1997 by Prof. Steve Jackson. Read more here.

23 Oct 2020: Morphogen-IX Ltd, a biotechnology spin-out from Cambridge Enterprise that is focused on the development of bone morphogenetic proteins (BMPs) for the treatment...

23 Oct 2020: We are delighted to announce that Cambridge Enterprise, the Cambridge Angels and Cambridge Capital Group have completed an initial round of investment...

23 Oct 2020: Amantys, Breathing Buildings and Enecsys, all developed from research developed at the University, are included in the golbal cleantech 100. Read more here.

23 Oct 2020: ROADMap today announced that it has successfully closed a funding round of $1.7 million by securing investment from a number of investors. Read more here.

23 Oct 2020: The second closing for Horizon Discovery was led by MVM Life Sciences LLP and was also subscribed to by a consortium of existing investors. Read more here.

23 Oct 2020: Cambridge Enterprise portfolio company Horizon Discovery has been ranked Number 23 in the 2013 Deloitte Technology Fast 50. Read more here.

23 Oct 2020: The remedy has proved hugely successful during clinical trials and may hasten the end of current reliance on local anaesthetics for dental pain.

23 Oct 2020: Lumora’s CEO Dr Laurence Tisi is this year’s winner of the Commercial Innovator Prize with Professor Jim Murray for the development of the BART system.

23 Oct 2020: The compound is a Protein Kinase B inhibitor, selected in January 2010 by AstraZeneca subsequent to its collaborative programme with Astex. Read more here.

23 Oct 2020: The University of Cambridge will establish a DeepMind Chair of Machine Learning, thanks to a benefaction from the world-leading British AI company.

23 Oct 2020: The University of Cambridge Enterprise Fund IV has been launched by Parkwalk Advisors in conjunction with Cambridge Enterprise. Read more here.

23 Oct 2020: Eight19's IndiGo system, which was launched in Kenya in September 2011, is now being deployed to rural off-grid communities in South Sudan. Read more here.

23 Oct 2020: Morphogen-IX Ltd, a preclinical biotechnology company focused on the development of bone morphogenetic proteins for the treatment of pulmonary arterial hypertension (PAH),...

23 Oct 2020: Astellas Pharma Inc. and Quethera Limited today announce that they have entered into an agreement for Astellas to acquire Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing novel treatments for ocular

23 Oct 2020: Cambridge Innovation Capital (CIC) has been established to provide funding that will help companies bridge the middle stage of commercial development.

23 Oct 2020: The European Entrepreneurship Colloquium is an intensive, one-week residential programme specifically designed for European professors and educators.

2 Dec 2020: Bond180, a provider of technology solutions for primary fixed income markets, today announced completion of a strategic funding round.

23 Oct 2020: A Mexican team is building a model that aims to identify various strategies for reducing carbon emissions. Read more here.

23 Oct 2020: Mammal cells usually contain two sets of chromosomes. The genetic information contained in these chromosome sets helps determine how our bodies develop.

23 Oct 2020: Arsenic contamination can cause a variety of health problems. This new test can detect arsenic in drinking water. Read more here.

23 Oct 2020: The reagents developed at Cambridge, such as antibodies, cell lines and hybridomas, are in great demand by the wider research community. Read more here.

23 Oct 2020: George Osborne chose Cambridge to unveil an historic £7 billion investment in science, praising the innovation cluster. Read more here.

23 Oct 2020: A new 'brain training' game designed by researchers at the University of Cambridge has been licensed through Cambridge Enterprise to app developer...

23 Oct 2020: Crohn’s disease and ulcerative colitis are increasingly common, chronic forms of inflammatory bowel disease which predominantly affect young adults.

23 Oct 2020: Cambridge Enterprise is pleased to announce that it has licensed intellectual property to Platelet BioGenesis, an American biotech start-up developing a method...

23 Oct 2020: Cambridge Innovation Capital plc (CIC), a preferred investor for the University of Cambridge, has raised £75 million of new capital.

23 Oct 2020: The University of Cambridge Enterprise funding allows alumni of the University to invest in new companies while benefitting from generous tax incentives.

23 Oct 2020: A formal collaboration between Cambridge’s Graphene Centre, and the University spin-out company, Plastic Logic, has been announced. Read more here.

23 Oct 2020: Keith O'Nions will assume stewardship of the Board in September, which is tasked with supporting commercialisation of ideas that emerge from the University.

23 Oct 2020: Under the terms of the agreement, SciGene will manufacture the new BlueGnome range of ClearHyb hybridisation and wash systems. Read more here.

23 Oct 2020: Chris White has been presented with the Rising Star New Engineer of the Year Award at the Elektra European Electronics Industry Awards 2012. Read more here.

23 Oct 2020: The University of Cambridge Open Innovation Forum will give researchers the chance to pitch their ideas to a panel from the food industry.

23 Oct 2020: Cambridge spin-out Metalysis has developed an innovative process that can transform natural rutile sands directly into titanium metal powder in one step.

23 Oct 2020: The Industry Engagement Forum is a new initiative by Cambridge Enterprise, funded by the Engineering and Physical Sciences Research Council. Read more here.

23 Oct 2020: Jukedeck, a Cambridge Enterprise portfolio company, has been named one of WIRED's '100 Hottest European Startups' in 2015. Read more here.

23 Oct 2020: Super-strong wires made from carbon nanotubes have been developed in a usable form for the first time. Read more here.

23 Oct 2020: The grant, awarded to Horizon Discovery, will be used to fund the development of new X-MANTM cell-lines. Read more here.

23 Oct 2020: The ‘Confidence in Concept’ awards will give 14 universities grants to help them progress promising medical research ideas towards clinical testing.

27 Nov 2020: Cambridge Enterprise is expanding its reach with the opening of an adjunct office on the first floor of the University’s School of Clinical Medicine.